Search for: "MYERS v. MYERS" Results 2121 - 2140 of 2,242
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Aug 2010, 3:17 pm by David Lat
— author of the colorful opinion in Gustafson v. [read post]
16 Feb 2010, 4:31 am by Broc Romanek
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
15 Oct 2012, 1:24 am by Kevin LaCroix
Supreme Court’s decision in Morrison v. [read post]
20 Aug 2024, 6:57 am by Bernard Bell
United States, 295 U.S. 602, 628-29 (1935)(limiting the holding in Myers v. [read post]
17 Dec 2020, 12:08 pm by Schachtman
Maine 2002); Sullivan v. [read post]
17 Dec 2020, 12:08 pm by admin
Maine 2002); Sullivan v. [read post]
8 May 2024, 6:00 am by Public Employment Law Press
IntegrateNYC, Inc. v State of New York2024 NY Slip Op 02369Decided on May 02, 2024Appellate Division, First DepartmentMoulton, J.Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.This opinion is uncorrected and subject to revision before publication in the Official Reports.Decided and Entered: May 02, 2024 SUPREME COURT, APPELLATE DIVISION First Judicial DepartmentSallie Manzanet-DanielsPeter H. [read post]
8 May 2024, 6:00 am by Public Employment Law Press
IntegrateNYC, Inc. v State of New York2024 NY Slip Op 02369Decided on May 02, 2024Appellate Division, First DepartmentMoulton, J.Published by New York State Law Reporting Bureau pursuant to Judiciary Law § 431.This opinion is uncorrected and subject to revision before publication in the Official Reports.Decided and Entered: May 02, 2024 SUPREME COURT, APPELLATE DIVISION First Judicial DepartmentSallie Manzanet-DanielsPeter H. [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
30 Sep 2011, 4:11 pm by Lyle Denniston
The case is Hosanna-Tabor Evangelical Lutheran Church and School v. [read post]
9 Nov 2015, 7:39 am
BackgroundOno owns a patent relating to immunotherapy -- specifically the use of anti-PD-1 antibodies for treating cancer (and Bristol-Myers Squibb is the exclusive licensee). [read post]